Literature DB >> 27891779

Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Elizabeth C Ailes1, Regina M Simeone1, April L Dawson1, Emily E Petersen2, Suzanne M Gilboa1.   

Abstract

BACKGROUND: Health insurance claims are a rich data source to examine medication use in pregnancy. Our objective was to identify pregnant women, their pregnancy outcomes, and date of their last menstrual period (LMP), and to estimate antidepressant dispensations in pregnancy.
METHODS: From a literature search, we identified diagnosis and procedure codes indicating the end of a pregnancy. Using Truven Health MarketScan® Commercial Claims and Encounters Databases, we identified all inpatient admissions and outpatient service claims with these codes. We developed an algorithm to assign: (1) pregnancy outcome (ectopic pregnancy, induced or spontaneous abortion, live birth, or stillbirth), and (2) estimated gestational age, to each inpatient or outpatient visit. For each pregnancy outcome, we estimated the LMP as the admission (for inpatient visits) or service (for outpatient visits) date minus the gestational age. To differentiate visits associated with separate pregnancies, we required ≥ 2 months between one pregnancy outcomes and the LMP of the next pregnancy. We used this algorithm to identify pregnancies in 2013 and to estimate the proportion of women who filled a prescription for an antidepressant from an outpatient pharmacy at various time points in pregnancy.
RESULTS: We identified 488,887 pregnancies in 2013; 79% resulted in a live birth. A prescription for an antidepressant was filled in 6.2% of pregnancies. Dispensations varied throughout pregnancy and were lowest (3.1%) during the second trimester.
CONCLUSION: This work will inform future efforts to estimate medication dispensations during critical periods of preconception, interconception, and pregnancy using health insurance claims data. Birth Defects Research (Part A) 106:927-934, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  MarketScan; SSRI; antidepressant; claims data; medication; pregnancy

Mesh:

Year:  2016        PMID: 27891779      PMCID: PMC5225464          DOI: 10.1002/bdra.23573

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  30 in total

1.  Use of an automated database to evaluate markers for early detection of pregnancy.

Authors:  J M Manson; B McFarland; S Weiss
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

2.  Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.

Authors:  Lockwood G Taylor; Rosenie Thelus Jean; Geoff Gordon; David Fram; Trinka Coster
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-03-31       Impact factor: 2.890

3.  Measuring Gestational Age in Vital Statistics Data: Transitioning to the Obstetric Estimate.

Authors:  Joyce A Martin; Michelle J K Osterman; Sharon E Kirmeyer; Elizabeth C W Gregory
Journal:  Natl Vital Stat Rep       Date:  2015-06-01

4.  Adherence of antidepressants during pregnancy: MEMS compared with three other methods.

Authors:  Judith Bosman; Peter G J Ter Horst; Jan Pieter Smit; Jeroen R Dijkstra; Hans R Beekhuis; Robbert J Slingersland; Wobbe Hospes
Journal:  Ther Adv Psychopharmacol       Date:  2014-04

5.  Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study.

Authors:  Angela Lupattelli; Olav Spigset; Ingunn Björnsdóttir; Katri Hämeen-Anttila; Ann-Charlotte Mårdby; Alice Panchaud; Romana Gjergja Juraski; Gorazd Rudolf; Marina Odalovic; Mariola Drozd; Michael J Twigg; Herbert Juch; Myla E Moretti; Debra Kennedy; Andre Rieutord; Ksenia Zagorodnikova; Anneke Passier; Hedvig Nordeng
Journal:  Depress Anxiety       Date:  2015-02-20       Impact factor: 6.505

6.  The identification of pregnancies within the general practice research database.

Authors:  Scott Devine; Suzanne West; Elizabeth Andrews; Pat Tennis; Tarek A Hammad; Susan Eaton; John Thorp; Andrew Olshan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-01       Impact factor: 2.890

7.  Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.

Authors:  Sarah C Tinker; Cheryl S Broussard; Meghan T Frey; Suzanne M Gilboa
Journal:  Matern Child Health J       Date:  2015-05

8.  Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.

Authors:  Allison L Naleway; Rachel Gold; Samantha Kurosky; Karen Riedlinger; Michelle L Henninger; James D Nordin; Elyse O Kharbanda; Stephanie Irving; T Craig Cheetham; Natalie L McCarthy
Journal:  Vaccine       Date:  2013-04-30       Impact factor: 3.641

9.  Patterns in the socioeconomic characteristics of women obtaining abortions in 2000-2001.

Authors:  Rachel K Jones; Jacqueline E Darroch; Stanley K Henshaw
Journal:  Perspect Sex Reprod Health       Date:  2002 Sep-Oct

10.  Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013.

Authors:  April L Dawson; Elizabeth C Ailes; Suzanne M Gilboa; Regina M Simeone; Jennifer N Lind; Sherry L Farr; Cheryl S Broussard; Jennita Reefhuis; Gerrard Carrino; Janis Biermann; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-29       Impact factor: 17.586

View more
  24 in total

1.  Machine learning on drug-specific data to predict small molecule teratogenicity.

Authors:  Anup P Challa; Andrew L Beam; Min Shen; Tyler Peryea; Robert R Lavieri; Ethan S Lippmann; David M Aronoff
Journal:  Reprod Toxicol       Date:  2020-05-16       Impact factor: 3.143

2.  Contraceptive methods of privately insured US women with congenital heart defects.

Authors:  Kayla N Anderson; Naomi K Tepper; Karrie Downing; Elizabeth C Ailes; Ginnie Abarbanell; Sherry L Farr
Journal:  Am Heart J       Date:  2020-01-21       Impact factor: 4.749

3.  Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects.

Authors:  Karrie F Downing; Naomi K Tepper; Regina M Simeone; Elizabeth C Ailes; Michelle Gurvitz; Sheree L Boulet; Margaret A Honein; Penelope P Howards; Anne M Valente; Sherry L Farr
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-08

4.  Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.

Authors:  Sarah C MacDonald; Jacqueline M Cohen; Alice Panchaud; Thomas F McElrath; Krista F Huybrechts; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-22       Impact factor: 2.890

5.  Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014).

Authors:  Julie M Petersen; Daina B Esposito; Martha M Werler
Journal:  Arch Womens Ment Health       Date:  2020-03-28       Impact factor: 3.633

6.  Pregnancy Outcomes in Women With Multiple Sclerosis.

Authors:  Sarah C MacDonald; Thomas F McElrath; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

7.  Association between preconception paternal health and pregnancy loss in the USA: an analysis of US claims data.

Authors:  Alex M Kasman; Chiyuan A Zhang; Shufeng Li; Ying Lu; Ruth B Lathi; David K Stevenson; Gary M Shaw; Michael L Eisenberg
Journal:  Hum Reprod       Date:  2021-02-18       Impact factor: 6.918

8.  Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy.

Authors:  Elizabeth Wall-Wieler; Thalia K Robakis; Carolyn E Cesta; Reem Masarwa; Deirdre J Lyell; Can Liu; Robert W Platt; Suzan L Carmichael
Journal:  Can J Psychiatry       Date:  2020-05-21       Impact factor: 4.356

9.  Benzodiazepine use before conception and risk of ectopic pregnancy.

Authors:  Elizabeth Wall-Wieler; Thalia K Robakis; Deirdre J Lyell; Reem Masarwa; Robert W Platt; Suzan L Carmichael
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

10.  Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.

Authors:  Jennifer L Ames; Christine Ladd-Acosta; M Daniele Fallin; Yinge Qian; Laura A Schieve; Carolyn DiGuiseppi; Li-Ching Lee; Eric P Kasten; Guoli Zhou; Jennifer Pinto-Martin; Ellen M Howerton; Christopher L Eaton; Lisa A Croen
Journal:  Biol Psychiatry       Date:  2021-04-14       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.